Company news
26 Metals Inc. (CSE:IRON) news
26 Metals Inc. news releases on 6ix. Latest, Aug 11, 2026: Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Press releases & updates
Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
August 11, 2026
Bolt Metals Announces Closing of Option to Acquire the High-Grade Floralia Iron Project
June 12, 2026
Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
May 22, 2026
Bolt Metals Executes Option to Acquire The High-Grade Floralia Iron Project, Prepares for Maiden Drill Program at Northwind
May 13, 2026
Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 12, 2026
Bolt Metals Corp. Announces Appointment of Chief Financial Officer and Corporate Secretary
April 9, 2026
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update
March 12, 2026
Bolt Metals Announces Upsize Non-Brokered Private Placement to $6,000,000
January 9, 2026
Bolt Metals Announces Private Placement
December 1, 2025
Bolt Metals Closes Second Tranche of LIFE Offering and Completes Unit Private Placement
December 1, 2025
Bolt Metals Closes Second Tranche of LIFE Offering and Completes Unit Private Placement
November 28, 2025
Bolt Metals Closes First Tranche of LIFE Offering
November 19, 2025
Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
November 12, 2025
Bolt Metals Announces Consolidation Of Common Shares
October 15, 2025
Bolt Metals Closes $600,000 Non-Brokered Private Placement
October 10, 2025
Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027
October 1, 2025
Bolt Metals Announces Non-Brokered Private Placement
September 29, 2025
Bolt Metals Appoints Mr. Zachary Kotowych as Chief Executive Officer and Director
September 24, 2025
Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
August 14, 2025
Bolt Metals Completes Debt Settlement
August 5, 2025
Bolt Metals Announces Debt Settlements
July 28, 2025
Bolt Metals Announces Debt Settlement
June 3, 2025
Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
May 12, 2025
Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates
May 8, 2025
Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody(TM) ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025
April 30, 2025
Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025
April 25, 2025
Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025
March 25, 2025
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
March 24, 2025
Bolt Biotherapeutics to Participate in Upcoming March Conferences
February 25, 2025
Bolt Metals Closes Debt Settlements
February 20, 2025
Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.
February 11, 2025
Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting
November 7, 2024
Bolt Biotherapeutics, Inc. May Have Violated Securities Laws And Shareholders Are Urged To Participate In A Case With The Schall Law Firm
September 6, 2024
Bolt Biotherapeutics Inc. May Have Violated Securities Regulations And Stakeholders Are Urged To Reach Out To The Schall Law Firm
September 4, 2024
Stakeholders Can Contact The Schall Law Firm About Joining A Case Against Bolt Biotherapeutics Inc. For Securities Law Infractions
September 2, 2024
Bolt Biotherapeutics Inc. Is Being Sued For Possibly Engaging In Securities Related Infractions And Shareholders Can Assist The Schall Law Firm
August 31, 2024
Bolt Biotherapeutics Inc. Is Being Sued For Securities Law Violations And Stockholders Are Invited To Contact The Schall Law Firm
August 29, 2024
The Schall Law Firm Is Suing Bolt Biotherapeutics, Inc. For Securities Law Violations And Stakeholders Are Urged To Join
August 23, 2024
Bolt Biotherapeutics, Inc. (BOLT) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates
May 30, 2024
Bolt Biotherapeutics, Inc. (BOLT) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
May 30, 2024
Bolt Biotherapeutics, Inc. Being Investigated on Behalf of Bolt Biotherapeutics, Inc. Investors. Contact Levi & Korsinsky For Details
May 28, 2024
Did Bolt Biotherapeutics, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - BOLT
May 22, 2024
Bolt Biotherapeutics, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - BOLT
May 22, 2024
Lost Money on Bolt Biotherapeutics, Inc. (BOLT)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
May 21, 2024
ATTENTION BOLT SHAREHOLDERS: Investors who Lost Money on Bolt Biotherapeutics, Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation
May 20, 2024
BOLT ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Bolt Biotherapeutics, Inc. Shareholders Who Lost Money
May 16, 2024
Bolt Metals Completes Share Consolidation
March 3, 2023
CSE Bulletin: Consolidation - Bolt Metals Corp. (BOLT)
March 1, 2023
Bolt Metals Announces Share Consolidation
February 26, 2023